Bleeding and thrombosis in a patient with primary antiphospholipid syndrome using norethisterone: a case report

Journal of Medical Case Reports

Mohsen El-Sherbiny El-Dahshan³  Mahmoud Wahid El-Ali²  Sawsan Abdullah Al Abdulhai¹ 

[1] Department of Rheumatology, Dammam Medical Complex, Dammam, Saudi Arabia;Department of Hematology, Dammam Medical Complex, Dammam, Saudi Arabia;Department of Radiology, Dammam Medical Complex, Dammam, Saudi Arabia

关键词: Thrombosis;    Bleeding;    Norethisterone;    Antiphospholipid syndrome;   

Others  :  1204630
DOI  :  10.1186/s13256-015-0554-3

 received in 2014-10-18, accepted in 2015-02-20,  发布年份 2015

【 摘 要 】

Introduction

Antiphospholipid syndrome is known to be associated with the occurrence of venous and/or arterial thrombosis. There are several factors that might trigger the risk of thrombosis in antiphospholipid syndrome, including drugs, however bleeding is rare. Only a few cases of antiphospholipid syndrome have reported simultaneous bleeding and thrombosis, and only a few of these cases have reported thrombosis induced by norethisterone when used by patients with an underlying risk factor for thromboembolism.

Case presentation

We report the case of a 35-year-old Saudi woman diagnosed with antiphospholipid syndrome with a history of several spontaneous miscarriages and two previous lower limb deep vein thromboses. She had used norethisterone to postpone her menstruation and presented to our institution with severe menorrhagia. During admission, she developed thrombocytopenia, and at the same time she was found to have extensive inferior vena cava and bilateral common iliac thrombosis.

Conclusions

This case report is of interest to rheumatologists, hematologists and radiologists because we have found that the presence of bleeding and thrombocytopenia do not preclude the concomitant occurrence of thrombotic complications of antiphospholipid syndrome. Norethisterone is normally safe to take, but it is not suitable for patients with an increased risk of deep vein thrombosis. Also, the simultaneous management of thrombosis and heavy vaginal bleeding is a challenge for clinicians since there are no evidence-based guidelines regarding the management of these patients.

【 授权许可】

   
2015 Al Abdulhai et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

Figure 9.

Figure 10.

【 参考文献 】

• [1]Bermas BL, Erkan D. Schur PH. Clinical manifestations of the antiphospholipid syndrome, Uptodate; 2012.
• [2]Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. From antiphospholipid syndrome overview of pathogenesis, diagnosis, and management. In: Rheumatology, vol. 2. 5th ed. Hochberg MC, editor. Mosby Elsevier, Philadelphia; 2011: p.1551-359.
• [3]Rangel ML, Alghamdi I, Contreras G, Harrington T, Thomas DB, Barisoni L et al.. Catastrophic antiphispholipid syndrome with concurrent thrombotic and hemorrhagic manifestations. Lupus. 2013; 22:855-64.
• [4]Rodriguez V, Reed AM, Kuntz NL, Anderson PM, Smithson WA, Nichols WL. Antiphospholipid syndrome with catastrophic bleeding and recurrent ischemic strokes as initial presentation of systemic lupus erythematosus. J Pediatr Hematol Oncol. 2005; 27:527-30.
• [5]Ramon I, Mathian A, Bachelot A, Hervier B, Haroche J, Boutin-Le ThiHuoung D et al.. Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infraction in the antiphospholipid syndrome: long term outcome of 16 patients. J Clin Endocrinol Metabol. 2013; 98:3179-89.
• [6]Ruiz-Irastorza G, Khamashta MA, Hunt BJ, Escudero A, Caudrado MJ, Hughes GR. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5. Arch Intern Med. 2002; 162:1164-9.
• [7]Vieregge GB, Harrington TJ, Andrews DM, Carpintero MF, Green DF, Nayer A. Catastrophic antiphospholipid syndrome with severe acute thrombotic microangiopathy and hemorrhagic complications. Case Rep Med. 2013; 2013:915309.
• [8]Park IC, Baek YH, Han SY, Lee SW, Chung WT, Lee SW et al.. Simultaneous intrahepatic and subgaleal hemorrhage in antiphospholipid syndrome following anticoagulation therapy. World J Gastroenterol. 2013; 19:6494-9.
• [9]Ramya T, Prakash B, Devi B. Norethisterone induced cerebral venous sinus thrombosis (CVST): a rate case report and review of literature. Int J Reprod Contracept Obstet Gynecol. 2014; 3:231-5.
• [10]National Health Service. United Kingdom: Datapharm Communications Limited. Norethisterone (Norethisterone 5mg tablets). http://www.nhs.uk/medicine-guides/pages/MedicineOverview.aspx?condition=Delaying%20menstruation&medicine=norethisterone. Accessed 3 March 2015.
• [11]Mansour D. Safer prescribing of therapeutic Norethisterone for women at risk of venous thromboembolism. J Fam Plann Reprod Health Care. 2012; 38:148-9.
• [12]Electronic Medicines Compendium. United Kingdom: Datapharm Communications Ltd; 2013. Primolut N®. http://www.medicines.org.uk/emc/medicine/1838/SPC. Accessed 3 March 2015.
• [13]Electronic Medicines Compendium. United Kingdom: Datapharm Communications Ltd; 2013. Norethisterone tablets. http://www.medicines.org.uk/emc/medicine/7257/spc. Accessed 3 March 2015.
• [14]Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS. From antiphospholipid syndrome. In: Kelley’s Textbook of Rheumatology. vol. 2. 8th ed. Firestein GS, editor. Saunders Elsvier, Philadelphia; 2009: p.1301-9.
• [15]Frastiero R. Bleeding in the antiphospholipid syndrome. Hematology. 2012; 17 Suppl 1:153-5.
• [16]Gardner A. More than immobility triggers in-flight clots. Norwalk, CT: Healthy Day®; 2006. http://consumer.healthday.com/cardiovascular-and-health-information-20/heart-stroke-related-stroke-353/more-than-immobility-triggers-in-flight-clots-531484.html. Accessed 3 March 2015.